Tag Archives: Alistair Burns: Professor of Old Age Psychiatry at University of Manchester

Support Workers for General Practice: Part of the NHS Comprehensive Personalised Care Model (BBC News / NHS England)

Posted on February 4, 2019 by Dementia and Elderly Care News

Summary Over 20,000 physiotherapists, pharmacists, paramedics, physician associates, and social prescribing support workers will be recruited by NHS England to work with general practices. The aim is to help relieve workload pressures on GPs. Full Text Link Reference GPs create … Continue reading →

Posted in BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, National, NHS, NHS England, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Standards, UK, Universal Interest | Tagged Ageing Population, Alistair Burns: NHS England’s National Clinical Director for Dementia, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Avoidable Hospital Admissions, BBC Health News, BMA General Practitioners Committee (GPC), Clinical Pharmacists, Directed Enhanced Service (DES), Dr Keith Ridge: Chief Pharmaceutical Officer, Expanded Services at Local GP Practices, Five-Year GP Services Contract, GP Contract Five-Year Framework, GP Contract Reform to Implement the NHS Long Term Plan: NHS England, Improving Access to Family Doctors, Integrated Care Systems, Integrated Care Systems (ICSs), Integrated Personal Budgets (IHBs), Longer Appointments for Complex Patients, Medication Reviews, NHS Comprehensive Personalised Care Model, NHS Long Term Plan (2019), NHS Long Term Plan: GP Services, NHS Long Term Plan: Implementation, Over-Medication, Paramedics, Patient Activation, People Powered Health and Supported Self-Management, Personal Health Budgets (PHBs), Personalised Care and Support Planning (PCSP), Pharmacists, Pharmacists to Cut Unnecessary Hospital Admissions, Pharmacy Reviews, Pharmacy Technicians, Physician Associates, Physiotherapists, Preventable Hospital Admissions, Primary Care Network (PCN) Contract, Primary Care Network Model, Primary Care Networks, Quality and Outcomes Framework (QOF), Quality and Outcomes Framework (QOF): Blood Pressure Control, Quality and Outcomes Framework (QOF): Diabetes, Quality and Outcomes Framework (QOF): End of Life Care, Quality and Outcomes Framework (QOF): Prescribing Safety, Reducing Delayed Transfers of Care, Reducing Over-Medication (NHS England), Reducing Re-Admissions to NHS Hospitals, Reducing Unnecessary Admissions, Reducing Unnecessary Medication (NHS England)), Reducing Unnecessary Transitions, Reducing Unnecessary Trips to Hospital, Reducing Unplanned Hospital Admissions, Reducing Unscheduled Admissions, Social Prescriber Link Workers, Social Prescribing, Social Prescribing Support Workers, Social Prescribing: Link Workers, Tackling Over-Medication, Technology to Support Personalised Health and Care, Technology-Supported Self-Management, Universal Personalised Care: Implementing the Comprehensive Model | Leave a comment

Historic Reduction in the Use of Antipsychotics for BPSD in UK General Practice? (Drug Safety)

Posted on August 23, 2017 by Dementia and Elderly Care News

Summary Data from 111,346 patients with dementia but without a concomitant diagnosis of psychosis indicates that prescribing of certain categories of antipsychotic drugs did reduce from 8.9% in 2001 to 1.4% in 2014. At face value, this reduction in inappropriate … Continue reading →

Developments in Dementia Research: From the Horses’ Mouths (NHS England / NIHR)

Posted on August 25, 2016 by Dementia and Elderly Care News

Summary Professor Alistair Burns (NHS England’s National Clinical Director for Dementia and Older Peoples’ Mental Health), and Professor Martin Rossor (NIHR National Director for Dementia Research), discuss current issues and new approaches in dementia research, touching briefly upon some of … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Models of Dementia Care, National, NHS England, NIHR, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged 100000 Genomes Project, A4 Study, Alistair Burns: Honorary Consultant Old Age Psychiatrist in the Manchester Mental Health and Social Care Trust (MMHSCT), Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Alzheimer's Prevention Initiative, Alzheimer’s Disease Biomarkers, Alzheimer’s Prevention Initiative Study, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study), APP and Presenilin, Asymptomatic Alzheimer’s Disease, Banner Alzheimer's Institute, Biomarkers, Chance Genetic Mutations, Colombia, Colombian Alzheimer's Prevention Initiative Registry in Medellín Antioquia, DIAN-TU Study, DIAN-TU Trial, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, Genentech, Genomics, Genomics England, Genomics in the NHS, Genomics-Based Medicine, Global Outlook, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Medellin (Colombia), Monoclonal Antibodies, MRC Neurochemical Pharmacology Unit, Mutational Signatures, National Clinical Director for Dementia, National Institute for Health Research (NIHR), National Institutes of Health (NIH), National Institutes of Health (US), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, NIHR Clinical Research Network, NIHR Dementia Translational Research Collaboration, NIHR National Director for Dementia Research, NIHR Translational Research Collaboration, Overcoming Barriers, Participation in Research, Participation in Research Studies, Preclinical Alzheimer's Disease, Presenilin, Prodromal Alzheimer's Disease, Professor Alistair Burns, Professor Martin Rossor: Director of the NIHR Queen Square Dementia Biomedical Research Unit, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: Former President of the Association of British Neurologists (2011-2013), Professor Martin Rossor: Honorary Consultant Neurologist at National Hospital for Neurology and Neurosurgery, Professor Martin Rossor: National Hospital (Queen Square), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Promisary Science, Reducing Downstream Effects of Disease, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Research Promotion, Sharing Knowledge and Information, Slowing Progression of Disease (Stabilisation), Solanezumab (Sola or Solab), Solanezumab: Humanised Monoclonal Antibody, Therapeutic Nihilism (Avoiding), Translational Research, UK Genomes Project: Genomics England, University of Southern California’s Alzheimer’s Therapeutic Research Institute, Washington University School of Medicine | Leave a comment

Timely Reflections on Dementia Awareness (NHS England / UKMi)

Posted on May 22, 2016 by Dementia and Elderly Care News

Summary Professor Alistair Burns, NHS England’s National Clinical Director for Dementia, marks National Dementia Awareness Week. Full Text Link Reference Great strides are being made in dementia awareness – Professor Alistair Burns. London: NHS England, May 20th 2016. Further elaboration, … Continue reading →

Posted in Alzheimer's Society, Diagnosis, For Carers (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Non-Pharmacological Treatments, Patient Care Pathway, Patient Information, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Ageing and Dementia, Ageing and Society, Alistair Burns, Alistair Burns: Honorary Consultant Old Age Psychiatrist in the Manchester Mental Health and Social Care Trust (MMHSCT), Alistair Burns: NHS England’s National Clinical Director for Dementia, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Awareness and Understanding, Awareness Campaigns, Barriers to Early Diagnosis, Care Planning, Delays in Diagnosis of Dementia, Dementia Awareness Week, Dementia Awareness Week (2016), Dementia Diagnosis, Dementia Diagnosis and Care in England, Dementia Diagnosis Rates, Dementia Friends, Dementia Friends Programme, Dementia Research, Dementia Research Funding, Dementia-Friendly Communities, Diagnosis, Diagnosis and Assessment, Diagnosis of Dementia, Early Diagnosis, Living Well with Dementia, medeConnect, Myth-Busting, Myths and Misconceptions About Dementia, National Dementia Awareness Week, National Dementia Helpline, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Post-Diagnostic Support, Reasons For Delays in Diagnosis of Dementia, Reducing Stigma, Southampton Medicines Advice Service, Staying Healthy for Longer, Stigma-Free Environments, Thinking Ahead: Dementia Awareness Week (Theme Revamped For 2016), Timely Diagnosis, UK Medicines Information (UKMi), UKMi, YouGov Plc | Leave a comment

Focus on Dementia – January 2016 Statistical Update (HSCIC / Alzheimer’s Society)

Posted on January 22, 2016 by Dementia and Elderly Care News

Summary The Health and Social Care Information Centre (HSCIC) has published statistics on dementia. These statistics focus on five strategic aspects of dementia care: Prevention. Diagnosis. Post-Diagnostic Support. Living Well With Dementia. Mortality Associated With Dementia. It may be of … Continue reading →

Tag Archives: Alistair Burns: Professor of Old Age Psychiatry at University of Manchester

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites